SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689813-20-000057
Filing Date
2020-08-10
Accepted
2020-08-10 17:21:15
Documents
95
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bhvn-20200630.htm   iXBRL 10-Q 1960971
2 EX-31.1 a2020q2bhvn10-qexh311.htm EX-31.1 16522
3 EX-31.2 a2020q2bhvn10-qexh312.htm EX-31.2 16619
4 EX-32.1 a2020q2bhvn10-qexh321.htm EX-32.1 10986
  Complete submission text file 0001689813-20-000057.txt   10046218

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20200630.xsd EX-101.SCH 84331
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20200630_cal.xml EX-101.CAL 90330
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20200630_def.xml EX-101.DEF 407254
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20200630_lab.xml EX-101.LAB 824642
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20200630_pre.xml EX-101.PRE 607415
10 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20200630_htm.xml XML 1808736
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38080 | Film No.: 201090383
SIC: 2834 Pharmaceutical Preparations